Stockreport

Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Globa...

Ocean Biomedical, Inc.  (OCEA) 
PDF development of compelling discoveries from top research scientists, today congratulates its joint venture partner , Virion Therapeutics, LLC, a clinical-stage biotechnol [Read more]